Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.3600 (-8%) ($7.3600 - $8.0800) on Thu. Apr. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.25% (three month average) | RSI | 65 | Latest Price | $7.3600(-8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -2.2% a day on average for past five trading days. | Weekly Trend | EYES advances 11.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) UUP(9%) ICLN(6%) UNG(6%) FIVG(5%) | Factors Impacting EYES price | EYES will decline at least -2.625% in a week (0% probabilities). BND(-8%) LQD(-6%) IDRV(-6%) XLP(-5%) VCIT(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.625% (StdDev 5.25%) | Hourly BBV | 0 () | Intraday Trend | -8.9% | | | |
|
5 Day Moving Average | $8.3(-11.33%) | 10 Day Moving Average | $8.02(-8.23%) | 20 Day Moving Average | $7.31(0.68%) | To recent high | -19.3% | To recent low | 34.3% | Market Cap | $2.351b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |